Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erector spinae block with bupivacaine versus bupivacaine + dexmedetomidine for postoperative analgesia after percutaneous nephrolithotomy
PACTR202311772437904Phase 3Completed
- Sponsor
- Souad Kafafi University Hospital
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in postoperative pain comparing Bupivacaine alone with Bupivacaine + dexmedetomidine (2 arms). Primary endpoint: Total morphine consumption. Started Jan 2021; status: completed.
02
Drugs
bupivacainedexmedetomidine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on PACTR202311772437904.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202311772437904.